Skip to Main Content

Paper Details

Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.
Am J Transl Res
40
2015
CDK2, EZH2, HER2, TNBC, Triple-negative breast cancer, basal-like breast cancer, breast cancer, cyclin E, enhancer of zeste 2, estrogen, estrogen receptor, pT416-EZH2, patients, triple negative breast cancers, tumor, tumorsphere
Author NameAffiliation
Yi-Hsin Elsa HsuThe University of Texas MD Anderson Cancer Center Houston
Jun YaoThe University of Texas MD Anderson Cancer Center Houston
Gabriel N HortobagyiThe University of Texas MD Anderson Cancer Center Houston
Mien-Chie HungThe University of Texas MD Anderson Cancer Center Houston, The University of Texas Health Science Center at Houston Houston, Texas 77030 Center for Molecular Medicine, and Graduate Institute of Cancer Biology, China Medical University Taichung 404, Asia University Taichung 413
  • 1 - 4

Datasets

Release 1.2